Subtopic Deep Dive

← Silicon Nanostructures and Photoluminescence

Porous Silicon Nanoparticles for Drug Delivery
Research Guide

What is Porous Silicon Nanoparticles for Drug Delivery?

Porous silicon nanoparticles are nanostructured silicon carriers fabricated by electrochemical etching, engineered for loading therapeutics and enabling controlled release in drug delivery applications.

These nanoparticles feature high surface area pores for drug encapsulation, pH-responsive degradation, and biocompatibility. Key studies demonstrate loading efficiencies exceeding 50% for chemotherapeutics like daunorubicin and doxorubicin (Chhablani et al., 2013; Tieu et al., 2020). Over 10 papers from 2013-2020, with 402 citations for top works, focus on fabrication, surface modification, and in vivo efficacy.

Curated Papers

Key Challenges

Why It Matters

Porous silicon nanoparticles improve cancer chemotherapy by providing sustained release and targeted delivery, as shown in Pseudomonas aeruginosa lung infection treatment (Kwon et al., 2017, 96 citations) and intraocular daunorubicin delivery without toxicity (Chhablani et al., 2013, 60 citations). They enable biolistic penetration into cancer cells (Zilony et al., 2013, 43 citations) and co-delivery of siRNA with doxorubicin using nanobody display (Tieu et al., 2020, 47 citations). Applications extend to uveitis wound healing via antibody loading (McInnes et al., 2015, 37 citations), enhancing therapeutic indices over traditional carriers.

Key Research Challenges

Controlled Drug Release Kinetics

Achieving precise pH-responsive and sustained release remains difficult due to variable pore sizes and surface interactions. Zhang et al. (2019, 55 citations) addressed spatial modification for tuning release, but scalability limits clinical translation. In vivo degradation rates vary, impacting efficacy (Tieu et al., 2018, 143 citations).

Surface Functionalization Stability

Covalent grafting of drugs or antibodies degrades under physiological conditions, reducing loading efficiency. Spivak et al. (2016, 52 citations) characterized functional groups via IR spectroscopy, yet long-term stability challenges persist. McInnes et al. (2015, 37 citations) optimized for infliximab release but noted hydrolysis issues.

In Vivo Targeting and Biocompatibility

Ensuring tumor-specific delivery without immune clearance is hindered by nanoparticle size and charge. Kwon et al. (2017, 96 citations) used tandem peptides for lung targeting, but systemic circulation efficacy varies. Tieu et al. (2020, 47 citations) improved with nanobodies, yet off-target effects remain.

Essential Papers

Layer-by-layer biofunctionalization of nanostructured porous silicon for high-sensitivity and high-selectivity label-free affinity biosensing

Stefano Mariani, Valentina Robbiano, Lucanos Marsilio Strambini et al. · 2018 · Nature Communications · 402 citations

Abstract Nanostructured materials premise to revolutionize the label-free biosensing of analytes for clinical applications, leveraging the deeper interaction between materials and analytes with com...

Advances in Porous Silicon–Based Nanomaterials for Diagnostic and Therapeutic Applications

Terence Tieu, Marı́a Alba, Roey Elnathan et al. · 2018 · Advanced Therapeutics · 143 citations

Abstract This review provides a perspective on porous silicon (pSi)–based nanomaterials including nanoparticles, nanowires, and thin films, that are currently being used in advanced therapy, imagin...

Porous Silicon Nanoparticle Delivery of Tandem Peptide Anti‐Infectives for the Treatment of <i>Pseudomonas aeruginosa</i> Lung Infections

Ester J. Kwon, Matthew Skalak, Alessandro Bertucci et al. · 2017 · Advanced Materials · 96 citations

There is an urgent need for new materials to treat bacterial infections. In order to improve antibacterial delivery, an anti‐infective nanomaterial is developed that utilizes two strategies for loc...

Oxidized Porous Silicon Particles Covalently Grafted with Daunorubicin as a Sustained Intraocular Drug Delivery System

Jay Chhablani, Alejandra Nieto, Huiyuan Hou et al. · 2013 · Investigative Ophthalmology & Visual Science · 60 citations

OPS with covalently loaded daunorubicin demonstrated sustained intravitreal drug release without ocular toxicity, which may be useful to inhibit unwanted intraocular proliferation.

Spatially Controlled Surface Modification of Porous Silicon for Sustained Drug Delivery Applications

Dexiang Zhang, Chiaki Yoshikawa, Nicholas G. Welch et al. · 2019 · Scientific Reports · 55 citations

Surface Functionality Features of Porous Silicon Prepared and Treated in Different Conditions

Yu. M. Spivak, S. V. Mjakin, В. А. Мошников et al. · 2016 · Journal of Nanomaterials · 52 citations

Hydrophilic layers of porous silicon are prepared by single- or two-step anodization and characterized by evaluating their surface hydrophilicity and contents of functional groups using IR spectros...

Scale-dependent diffusion anisotropy in nanoporous silicon

Daria Kondrashova, Alexander Lauerer, Dirk Mehlhorn et al. · 2017 · Scientific Reports · 50 citations

Reading Guide

Foundational Papers

Start with Chhablani et al. (2013, 60 citations) for covalent daunorubicin loading and sustained release basics, then Zilony et al. (2013, 43 citations) for biolistic cancer delivery paradigms.

Recent Advances

Study Tieu et al. (2020, 47 citations) on nanobody co-delivery and Zhang et al. (2019, 55 citations) for spatial surface control as key advances.

Core Methods

Core techniques include electrochemical anodization, covalent grafting via oxidation, layer-by-layer assembly (Mariani et al., 2018), and nanobody display (Tieu et al., 2020).

How PapersFlow Helps You Research Porous Silicon Nanoparticles for Drug Delivery

Discover & Search

Research Agent uses searchPapers and exaSearch to find core papers like 'Advances in Porous Silicon–Based Nanomaterials for Diagnostic and Therapeutic Applications' by Tieu et al. (2018), then citationGraph reveals 143 citing works on drug release, while findSimilarPapers uncovers related functionalization studies.

Analyze & Verify

Analysis Agent applies readPaperContent to extract release kinetics data from Kwon et al. (2017), verifies claims with CoVe against Chhablani et al. (2013), and runs PythonAnalysis with NumPy/pandas to model diffusion from Kondrashova et al. (2017) data, graded via GRADE for statistical reliability.

Synthesize & Write

Synthesis Agent detects gaps in pH-responsive targeting from Tieu et al. (2020) vs. Zhang et al. (2019), flags contradictions in degradation rates; Writing Agent uses latexEditText, latexSyncCitations for review drafts, and latexCompile to generate figures of release profiles with exportMermaid for pore diagrams.

Use Cases

"Analyze release kinetics of daunorubicin from porous silicon nanoparticles in Chhablani 2013."

Analysis Agent → readPaperContent (extracts data) → runPythonAnalysis (fits exponential decay model with matplotlib) → GRADE-verified kinetics plot and half-life stats.

"Write a LaTeX review section on surface-modified porous silicon for antibody delivery."

Synthesis Agent → gap detection (McInnes 2015 vs Spivak 2016) → Writing Agent → latexEditText (drafts section) → latexSyncCitations (adds refs) → latexCompile (PDF output with infliximab release figure).

"Find open-source code for simulating porous silicon drug diffusion models."

Research Agent → paperExtractUrls (from Kondrashova 2017) → paperFindGithubRepo (locates diffusion sims) → githubRepoInspect (reviews NumPy code) → runPythonAnalysis (tests on custom pore data).

Automated Workflows

Deep Research workflow scans 50+ papers via searchPapers on 'porous silicon drug delivery,' chains citationGraph to Tieu et al. (2018), and outputs structured report with release efficiency tables. DeepScan applies 7-step analysis to Kwon et al. (2017) with CoVe checkpoints for in vivo claims verification. Theorizer generates hypotheses on nanobody-pSi synergies from Tieu et al. (2020) and McInnes et al. (2015).

Try Doxa for Porous Silicon Nanoparticles for Drug Delivery Research

Frequently Asked Questions

What defines porous silicon nanoparticles for drug delivery?

They are electrochemically etched silicon nanostructures with tunable pores (10-100 nm) for high drug loading and biodegradable release, as in Chhablani et al. (2013).

What are key fabrication methods?

Electrochemical anodization followed by surface oxidation or layer-by-layer biofunctionalization enables drug grafting, per Mariani et al. (2018, 402 citations) and Spivak et al. (2016).

What are the most cited papers?

Top works include Mariani et al. (2018, 402 citations) on biosensing functionalization and Tieu et al. (2018, 143 citations) reviewing therapeutic nanomaterials.

What open problems exist?

Scalable in vivo targeting, long-term stability of covalent drug links, and standardized release kinetics modeling persist, as noted in Zhang et al. (2019) and Tieu et al. (2020).